Molecular Partners AG (SWX:MOLN)
3.330
-0.060 (-1.77%)
Sep 11, 2026, 5:30 PM CET
Molecular Partners AG Employees
Molecular Partners AG had 134 employees as of December 31, 2025. The number of employees decreased by 25 or -15.46% compared to the previous year.
Employees
134
Change (1Y)
-25
Growth (1Y)
-15.46%
Revenue / Employee
n/a
Profits / Employee
-381.99K CHF
Market Cap
127.56M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 134 | -25 | -15.46% |
| Dec 31, 2024 | 159 | -9 | -5.37% |
| Dec 31, 2023 | 168 | -8 | -4.45% |
| Dec 31, 2022 | 175 | 12 | 7.41% |
| Dec 31, 2021 | 163 | 18 | 12.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bachem Holding AG | 2,725 |
| Idorsia | 487 |
| Basilea Pharmaceutica AG | 200 |
| Santhera Pharmaceuticals Holding AG | 94 |
| BioVersys AG | 33 |
| Newron Pharmaceuticals | 27 |
| Xlife Sciences AG | 20 |
| Addex Therapeutics | 3 |
Molecular Partners AG News
- 7 days ago - Clear Street transfers coverage on Molecular Partners, keeps Buy rating - TheFly
- 17 days ago - Molecular Partners Reports H1 2026 Results, Advances DLL3 Radiotherapy MP0712 - Nasdaq
- 17 days ago - Molecular Partners AG Slides: Q2 2026 - Filings
- 17 days ago - Molecular Partners AG Earnings release: Q2 2026 - Filings
- 18 days ago - Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study - GlobeNewsWire
- 1 month ago - Molecular Partners doses first patients in MP0317 combination study - TheFly
- 1 month ago - Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference - GlobeNewsWire
- 2 months ago - Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics - GlobeNewsWire